The Therapeutic Manufacturing Resource supports the development and manufacture of novel biological molecules and innovative cell-based therapies for Phase I/II clinical testing. These facilities permit the reproducible production of large-scale quantities of biological reagents and therapeutic cells under the strict quality control and safety conditions required by the FDA for human studies.